Association between elevated blood glucose level and non-valvular atrial fibrillation: a report from the Guangzhou heart study

To estimate the prevalence of elevated blood glucose level (EBG, including type 2 diabetes mellitus and impaired fasting glucose), and its association with non-valvular atrial fibrillation (NVAF) in Guangzhou, China. The population-based follow-up Guangzhou Heart Study collected baseline data from J...

Full description

Saved in:
Bibliographic Details
Published inBMC cardiovascular disorders Vol. 19; no. 1; pp. 270 - 8
Main Authors Fu, Lu, Deng, Hai, Lin, Wei-dong, He, Shang-fei, Liu, Fang-zhou, Liu, Yang, Zhan, Xian-zhang, Fang, Xian-hong, Liao, Hong-tao, Wei, Wei, Liao, Zi-li, Tang, Li-hong, Fu, Zu-yi, Zheng, Mu-rui, Wu, Shu-lin, Xue, Yu-mei
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 28.11.2019
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract To estimate the prevalence of elevated blood glucose level (EBG, including type 2 diabetes mellitus and impaired fasting glucose), and its association with non-valvular atrial fibrillation (NVAF) in Guangzhou, China. The population-based follow-up Guangzhou Heart Study collected baseline data from July 2015 to August 2017 among 12,013 permanent residents aged > 35 from 4 Guangzhou districts. Two streets (Dadong and Baiyun) in the Yuexiu District, and one street (Xiaoguwei) and two towns (Xinzao and Nancun) in the Panyu District were chosen as representative of urban and rural areas, respectively. Each participant completed a comprehensive questionnaire, and underwent physical examination, blood sample collection for laboratory testing, electrocardiography, and other evaluations. Multivariable logistic regression analyses were used to estimate the independent association between hyperglycemia and NVAF prevalence. The prevalence of EBG in overall study population was 29.9%. Compared with residents without EBG, the odds ratio (OR) for AF among residents with EBG was significantly higher (1.94, 95% confidence interval [CI]: 1.40-2.70, P <  0.001), even after multivariate adjustment for metabolic abnormalities (OR = 1.60, 95% CI: 1.14-2.25, P = 0.007), and driven by women (OR = 1.80, 95% CI: 1.12-2.91, P = 0.016). In Guangzhou, China, prevalence of EBG is high among residents aged > 35 years and associated with a multivariate adjusted increase in prevalence of NVAF overall and in women.
AbstractList To estimate the prevalence of elevated blood glucose level (EBG, including type 2 diabetes mellitus and impaired fasting glucose), and its association with non-valvular atrial fibrillation (NVAF) in Guangzhou, China. The population-based follow-up Guangzhou Heart Study collected baseline data from July 2015 to August 2017 among 12,013 permanent residents aged 35 from 4 Guangzhou districts. Two streets (Dadong and Baiyun) in the Yuexiu District, and one street (Xiaoguwei) and two towns (Xinzao and Nancun) in the Panyu District were chosen as representative of urban and rural areas, respectively. Each participant completed a comprehensive questionnaire, and underwent physical examination, blood sample collection for laboratory testing, electrocardiography, and other evaluations. Multivariable logistic regression analyses were used to estimate the independent association between hyperglycemia and NVAF prevalence. The prevalence of EBG in overall study population was 29.9%. Compared with residents without EBG, the odds ratio (OR) for AF among residents with EBG was significantly higher (1.94, 95% confidence interval [CI]: 1.40-2.70, P < 0.001), even after multivariate adjustment for metabolic abnormalities (OR = 1.60, 95% CI: 1.14-2.25, P = 0.007), and driven by women (OR = 1.80, 95% CI: 1.12-2.91, P = 0.016). In Guangzhou, China, prevalence of EBG is high among residents aged 35 years and associated with a multivariate adjusted increase in prevalence of NVAF overall and in women.
Abstract Background To estimate the prevalence of elevated blood glucose level (EBG, including type 2 diabetes mellitus and impaired fasting glucose), and its association with non-valvular atrial fibrillation (NVAF) in Guangzhou, China. Methods The population-based follow-up Guangzhou Heart Study collected baseline data from July 2015 to August 2017 among 12,013 permanent residents aged > 35 from 4 Guangzhou districts. Two streets (Dadong and Baiyun) in the Yuexiu District, and one street (Xiaoguwei) and two towns (Xinzao and Nancun) in the Panyu District were chosen as representative of urban and rural areas, respectively. Each participant completed a comprehensive questionnaire, and underwent physical examination, blood sample collection for laboratory testing, electrocardiography, and other evaluations. Multivariable logistic regression analyses were used to estimate the independent association between hyperglycemia and NVAF prevalence. Results The prevalence of EBG in overall study population was 29.9%. Compared with residents without EBG, the odds ratio (OR) for AF among residents with EBG was significantly higher (1.94, 95% confidence interval [CI]: 1.40–2.70, P <  0.001), even after multivariate adjustment for metabolic abnormalities (OR = 1.60, 95% CI: 1.14–2.25, P = 0.007), and driven by women (OR = 1.80, 95% CI: 1.12–2.91, P = 0.016). Conclusions In Guangzhou, China, prevalence of EBG is high among residents aged > 35 years and associated with a multivariate adjusted increase in prevalence of NVAF overall and in women.
To estimate the prevalence of elevated blood glucose level (EBG, including type 2 diabetes mellitus and impaired fasting glucose), and its association with non-valvular atrial fibrillation (NVAF) in Guangzhou, China. The population-based follow-up Guangzhou Heart Study collected baseline data from July 2015 to August 2017 among 12,013 permanent residents aged > 35 from 4 Guangzhou districts. Two streets (Dadong and Baiyun) in the Yuexiu District, and one street (Xiaoguwei) and two towns (Xinzao and Nancun) in the Panyu District were chosen as representative of urban and rural areas, respectively. Each participant completed a comprehensive questionnaire, and underwent physical examination, blood sample collection for laboratory testing, electrocardiography, and other evaluations. Multivariable logistic regression analyses were used to estimate the independent association between hyperglycemia and NVAF prevalence. The prevalence of EBG in overall study population was 29.9%. Compared with residents without EBG, the odds ratio (OR) for AF among residents with EBG was significantly higher (1.94, 95% confidence interval [CI]: 1.40-2.70, P <  0.001), even after multivariate adjustment for metabolic abnormalities (OR = 1.60, 95% CI: 1.14-2.25, P = 0.007), and driven by women (OR = 1.80, 95% CI: 1.12-2.91, P = 0.016). In Guangzhou, China, prevalence of EBG is high among residents aged > 35 years and associated with a multivariate adjusted increase in prevalence of NVAF overall and in women.
Background To estimate the prevalence of elevated blood glucose level (EBG, including type 2 diabetes mellitus and impaired fasting glucose), and its association with non-valvular atrial fibrillation (NVAF) in Guangzhou, China. Methods The population-based follow-up Guangzhou Heart Study collected baseline data from July 2015 to August 2017 among 12,013 permanent residents aged > 35 from 4 Guangzhou districts. Two streets (Dadong and Baiyun) in the Yuexiu District, and one street (Xiaoguwei) and two towns (Xinzao and Nancun) in the Panyu District were chosen as representative of urban and rural areas, respectively. Each participant completed a comprehensive questionnaire, and underwent physical examination, blood sample collection for laboratory testing, electrocardiography, and other evaluations. Multivariable logistic regression analyses were used to estimate the independent association between hyperglycemia and NVAF prevalence. Results The prevalence of EBG in overall study population was 29.9%. Compared with residents without EBG, the odds ratio (OR) for AF among residents with EBG was significantly higher (1.94, 95% confidence interval [CI]: 1.40–2.70, P <  0.001), even after multivariate adjustment for metabolic abnormalities (OR = 1.60, 95% CI: 1.14–2.25, P = 0.007), and driven by women (OR = 1.80, 95% CI: 1.12–2.91, P = 0.016). Conclusions In Guangzhou, China, prevalence of EBG is high among residents aged > 35 years and associated with a multivariate adjusted increase in prevalence of NVAF overall and in women.
To estimate the prevalence of elevated blood glucose level (EBG, including type 2 diabetes mellitus and impaired fasting glucose), and its association with non-valvular atrial fibrillation (NVAF) in Guangzhou, China.BACKGROUNDTo estimate the prevalence of elevated blood glucose level (EBG, including type 2 diabetes mellitus and impaired fasting glucose), and its association with non-valvular atrial fibrillation (NVAF) in Guangzhou, China.The population-based follow-up Guangzhou Heart Study collected baseline data from July 2015 to August 2017 among 12,013 permanent residents aged > 35 from 4 Guangzhou districts. Two streets (Dadong and Baiyun) in the Yuexiu District, and one street (Xiaoguwei) and two towns (Xinzao and Nancun) in the Panyu District were chosen as representative of urban and rural areas, respectively. Each participant completed a comprehensive questionnaire, and underwent physical examination, blood sample collection for laboratory testing, electrocardiography, and other evaluations. Multivariable logistic regression analyses were used to estimate the independent association between hyperglycemia and NVAF prevalence.METHODSThe population-based follow-up Guangzhou Heart Study collected baseline data from July 2015 to August 2017 among 12,013 permanent residents aged > 35 from 4 Guangzhou districts. Two streets (Dadong and Baiyun) in the Yuexiu District, and one street (Xiaoguwei) and two towns (Xinzao and Nancun) in the Panyu District were chosen as representative of urban and rural areas, respectively. Each participant completed a comprehensive questionnaire, and underwent physical examination, blood sample collection for laboratory testing, electrocardiography, and other evaluations. Multivariable logistic regression analyses were used to estimate the independent association between hyperglycemia and NVAF prevalence.The prevalence of EBG in overall study population was 29.9%. Compared with residents without EBG, the odds ratio (OR) for AF among residents with EBG was significantly higher (1.94, 95% confidence interval [CI]: 1.40-2.70, P <  0.001), even after multivariate adjustment for metabolic abnormalities (OR = 1.60, 95% CI: 1.14-2.25, P = 0.007), and driven by women (OR = 1.80, 95% CI: 1.12-2.91, P = 0.016).RESULTSThe prevalence of EBG in overall study population was 29.9%. Compared with residents without EBG, the odds ratio (OR) for AF among residents with EBG was significantly higher (1.94, 95% confidence interval [CI]: 1.40-2.70, P <  0.001), even after multivariate adjustment for metabolic abnormalities (OR = 1.60, 95% CI: 1.14-2.25, P = 0.007), and driven by women (OR = 1.80, 95% CI: 1.12-2.91, P = 0.016).In Guangzhou, China, prevalence of EBG is high among residents aged > 35 years and associated with a multivariate adjusted increase in prevalence of NVAF overall and in women.CONCLUSIONSIn Guangzhou, China, prevalence of EBG is high among residents aged > 35 years and associated with a multivariate adjusted increase in prevalence of NVAF overall and in women.
Background To estimate the prevalence of elevated blood glucose level (EBG, including type 2 diabetes mellitus and impaired fasting glucose), and its association with non-valvular atrial fibrillation (NVAF) in Guangzhou, China. Methods The population-based follow-up Guangzhou Heart Study collected baseline data from July 2015 to August 2017 among 12,013 permanent residents aged 35 from 4 Guangzhou districts. Two streets (Dadong and Baiyun) in the Yuexiu District, and one street (Xiaoguwei) and two towns (Xinzao and Nancun) in the Panyu District were chosen as representative of urban and rural areas, respectively. Each participant completed a comprehensive questionnaire, and underwent physical examination, blood sample collection for laboratory testing, electrocardiography, and other evaluations. Multivariable logistic regression analyses were used to estimate the independent association between hyperglycemia and NVAF prevalence. Results The prevalence of EBG in overall study population was 29.9%. Compared with residents without EBG, the odds ratio (OR) for AF among residents with EBG was significantly higher (1.94, 95% confidence interval [CI]: 1.40-2.70, P < 0.001), even after multivariate adjustment for metabolic abnormalities (OR = 1.60, 95% CI: 1.14-2.25, P = 0.007), and driven by women (OR = 1.80, 95% CI: 1.12-2.91, P = 0.016). Conclusions In Guangzhou, China, prevalence of EBG is high among residents aged 35 years and associated with a multivariate adjusted increase in prevalence of NVAF overall and in women. Keywords: Hyperglycemia, Type 2 diabetes mellitus, Impaired fasting glucose, Non-valvular atrial fibrillation, Sex
ArticleNumber 270
Audience Academic
Author Wu, Shu-lin
Wei, Wei
Fu, Zu-yi
Liu, Yang
Liu, Fang-zhou
Zhan, Xian-zhang
Fang, Xian-hong
Liao, Hong-tao
Tang, Li-hong
Zheng, Mu-rui
Deng, Hai
Xue, Yu-mei
Fu, Lu
Liao, Zi-li
He, Shang-fei
Lin, Wei-dong
Author_xml – sequence: 1
  givenname: Lu
  surname: Fu
  fullname: Fu, Lu
– sequence: 2
  givenname: Hai
  surname: Deng
  fullname: Deng, Hai
– sequence: 3
  givenname: Wei-dong
  surname: Lin
  fullname: Lin, Wei-dong
– sequence: 4
  givenname: Shang-fei
  surname: He
  fullname: He, Shang-fei
– sequence: 5
  givenname: Fang-zhou
  surname: Liu
  fullname: Liu, Fang-zhou
– sequence: 6
  givenname: Yang
  surname: Liu
  fullname: Liu, Yang
– sequence: 7
  givenname: Xian-zhang
  surname: Zhan
  fullname: Zhan, Xian-zhang
– sequence: 8
  givenname: Xian-hong
  surname: Fang
  fullname: Fang, Xian-hong
– sequence: 9
  givenname: Hong-tao
  surname: Liao
  fullname: Liao, Hong-tao
– sequence: 10
  givenname: Wei
  surname: Wei
  fullname: Wei, Wei
– sequence: 11
  givenname: Zi-li
  surname: Liao
  fullname: Liao, Zi-li
– sequence: 12
  givenname: Li-hong
  surname: Tang
  fullname: Tang, Li-hong
– sequence: 13
  givenname: Zu-yi
  surname: Fu
  fullname: Fu, Zu-yi
– sequence: 14
  givenname: Mu-rui
  surname: Zheng
  fullname: Zheng, Mu-rui
– sequence: 15
  givenname: Shu-lin
  surname: Wu
  fullname: Wu, Shu-lin
– sequence: 16
  givenname: Yu-mei
  orcidid: 0000-0001-7354-0014
  surname: Xue
  fullname: Xue, Yu-mei
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31779588$$D View this record in MEDLINE/PubMed
BookMark eNp1kk1vEzEQhleoiH7AD-CCLHHhssUfu7aXA1JUtaVSJS5wtrz2OHHkrIO9m6oc-O04SQtNBfLB1sw7j2dG72l1NMQBquotweeESP4xEyoFrTHpakJbVvMX1QlpBKkp5eToyfu4Os15iTEREnevqmNGhOhaKU-qX7Oco_F69HFAPYx3AAOCABs9gkV9iNGieZhMzIBKFALSg0Wlj3qjw2YKOiE9Jq8Dcr5PPoQd6RPSKME6phG5FFdoXAC6nvQw_7mIE1qALok8Tvb-dfXS6ZDhzcN9Vn2_uvx28aW-_Xp9czG7rU3L8VizRmMJjnROWCLBtLqXhJEGCNbGtT3nFEssCaWCNU2ZUWjroHEMd5ZSZ9hZdbPn2qiXap38Sqd7FbVXu0BMc1V68iaAYqLhPbSm8HBDudVSENN0vTW67VstCuvznrWe-hVYA8OYdDiAHmYGv1DzuFFcSsZlVwAfHgAp_pggj2rls4GyuwHilBVlFDPRdR0r0vfPpMs4paGsaquStGOtoH9Vc10G8IOL5V-zhaoZx6IhDZFb1fk_VOVYWHlTnOV8iR8UvHs66J8JH91TBGIvMCnmnMAp48edAQrZB0Ww2vpU7X2qik_V1qeKl0ryrPIR_v-a3w-P6j0
CitedBy_id crossref_primary_10_1002_joa3_12938
crossref_primary_10_3390_mca29050084
crossref_primary_10_3389_fendo_2022_895843
crossref_primary_10_3390_medicina57121357
crossref_primary_10_26599_1671_5411_2023_04_008
crossref_primary_10_4103_hm_HM_D_23_00028
crossref_primary_10_1186_s12933_021_01216_7
crossref_primary_10_4239_wjd_v14_i8_1163
crossref_primary_10_2147_CLEP_S399920
Cites_doi 10.7326/0003-4819-150-9-200905050-00006
10.1016/S0140-6736(05)66375-1
10.1016/j.jacc.2012.06.030
10.1016/S0140-6736(09)60443-8
10.1016/j.ahj.2013.08.012
10.1093/qjmed/hcm044
10.1093/eurheartj/ehm400
10.1056/NEJM198204293061703
10.1016/S0002-9343(02)01236-6
10.1016/j.ijcard.2018.02.051
10.1161/01.HYP.0000146691.51307.84
10.1378/chest.14-0321
10.1016/S0140-6736(98)07037-8
10.1161/CIRCULATIONAHA.105.595140
10.1016/S0002-9149(98)00736-X
10.1161/CIRCULATIONAHA.109.192644
10.1093/eurheartj/ehx316
10.1016/j.amjcard.2011.03.004
10.1161/01.CIR.0000140263.20897.42
10.2337/diacare.28.suppl_1.S37
10.1038/s41598-018-35928-w
10.1161/CIRCULATIONAHA.113.005119
10.1016/j.ijcard.2005.02.050
10.1161/CIR.0000000000000040
10.2188/jea.JE2008021
10.1016/j.jacc.2006.08.060
ContentType Journal Article
Copyright COPYRIGHT 2019 BioMed Central Ltd.
2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s). 2019
Copyright_xml – notice: COPYRIGHT 2019 BioMed Central Ltd.
– notice: 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s). 2019
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QP
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12872-019-1253-6
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

MEDLINE
Publicly Available Content Database
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-2261
EndPage 8
ExternalDocumentID oai_doaj_org_article_3746be5c8080426da871c49bdca5b5a7
PMC6883689
A607414182
31779588
10_1186_s12872_019_1253_6
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations China
Guangzhou China
GeographicLocations_xml – name: China
– name: Guangzhou China
GrantInformation_xml – fundername: ;
  grantid: 2014Y2-00196; 201508020261
– fundername: ;
  grantid: 81870254
GroupedDBID ---
0R~
23N
2WC
53G
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
ECGQY
EMB
EMOBN
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
UKHRP
W2D
WOQ
WOW
XSB
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
3V.
7QP
7XB
8FK
AZQEC
DWQXO
EJD
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c560t-34a08ef19f7d18ec5ab81314e10acf5b662080812273448097adfe4f309d22fc3
IEDL.DBID M48
ISSN 1471-2261
IngestDate Wed Aug 27 01:30:39 EDT 2025
Thu Aug 21 17:18:50 EDT 2025
Thu Jul 10 18:10:56 EDT 2025
Fri Jul 25 22:44:09 EDT 2025
Tue Jun 17 21:30:19 EDT 2025
Tue Jun 10 20:19:15 EDT 2025
Thu Apr 03 07:02:33 EDT 2025
Tue Jul 01 02:37:50 EDT 2025
Thu Apr 24 23:09:11 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Hyperglycemia
Impaired fasting glucose
Type 2 diabetes mellitus
Non-valvular atrial fibrillation
Sex
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c560t-34a08ef19f7d18ec5ab81314e10acf5b662080812273448097adfe4f309d22fc3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-7354-0014
OpenAccessLink https://www.proquest.com/docview/2328293572?pq-origsite=%requestingapplication%
PMID 31779588
PQID 2328293572
PQPubID 44077
PageCount 8
ParticipantIDs doaj_primary_oai_doaj_org_article_3746be5c8080426da871c49bdca5b5a7
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6883689
proquest_miscellaneous_2320379993
proquest_journals_2328293572
gale_infotracmisc_A607414182
gale_infotracacademiconefile_A607414182
pubmed_primary_31779588
crossref_citationtrail_10_1186_s12872_019_1253_6
crossref_primary_10_1186_s12872_019_1253_6
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-11-28
PublicationDateYYYYMMDD 2019-11-28
PublicationDate_xml – month: 11
  year: 2019
  text: 2019-11-28
  day: 28
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC cardiovascular disorders
PublicationTitleAlternate BMC Cardiovasc Disord
PublicationYear 2019
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References SS Chugh (1253_CR3) 2014; 129
WS Leslie (1253_CR14) 2007; 100
AS Gami (1253_CR24) 2007; 49
D Gu (1253_CR10) 2005; 365
S Stewart (1253_CR2) 2002; 113
RB Schnabel (1253_CR6) 2009; 373
UK Prospective Diabetes Study (UKPDS) Group (1253_CR12) 1998; 352
CT January (1253_CR18) 2014; 130
MM Gallagher (1253_CR17) 1998; 82
DM Lloyd-Jones (1253_CR23) 2004; 110
AS Levey (1253_CR21) 2009; 150
H Deng (1253_CR15) 2018; 8
MR Movahed (1253_CR25) 2005; 105
KG Alberti (1253_CR20) 2009; 120
American Diabetes Association (1253_CR19) 2005; 28
WB Kannel (1253_CR1) 1982; 306
P Korantzopoulos (1253_CR5) 2005; 293
T Schoen (1253_CR28) 2012; 60
Y Li (1253_CR7) 2018; 261
SS Lee (1253_CR9) 2017; 38
L Niskanen (1253_CR13) 2004; 44
EJ Benjamin (1253_CR4) 1994; 271
R Latini (1253_CR27) 2013; 166
Z Zhou (1253_CR16) 2008; 18
Y Miyasaka (1253_CR22) 2006; 114
Y Guo (1253_CR26) 2015; 147
RR Huxley (1253_CR8) 2011; 108
D Conen (1253_CR11) 2007; 28
References_xml – volume: 150
  start-page: 604
  year: 2009
  ident: 1253_CR21
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-150-9-200905050-00006
– volume: 365
  start-page: 1398
  year: 2005
  ident: 1253_CR10
  publication-title: Lancet
  doi: 10.1016/S0140-6736(05)66375-1
– volume: 293
  start-page: 1974
  year: 2005
  ident: 1253_CR5
  publication-title: JAMA
– volume: 60
  start-page: 1421
  year: 2012
  ident: 1253_CR28
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2012.06.030
– volume: 373
  start-page: 739
  year: 2009
  ident: 1253_CR6
  publication-title: Lancet
  doi: 10.1016/S0140-6736(09)60443-8
– volume: 166
  start-page: 935
  year: 2013
  ident: 1253_CR27
  publication-title: Am Heart J
  doi: 10.1016/j.ahj.2013.08.012
– volume: 100
  start-page: 395
  year: 2007
  ident: 1253_CR14
  publication-title: Q J Med
  doi: 10.1093/qjmed/hcm044
– volume: 28
  start-page: 2937
  year: 2007
  ident: 1253_CR11
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehm400
– volume: 306
  start-page: 1018
  year: 1982
  ident: 1253_CR1
  publication-title: N Engl J Med
  doi: 10.1056/NEJM198204293061703
– volume: 113
  start-page: 359
  year: 2002
  ident: 1253_CR2
  publication-title: Am J Med
  doi: 10.1016/S0002-9343(02)01236-6
– volume: 261
  start-page: 92
  year: 2018
  ident: 1253_CR7
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2018.02.051
– volume: 44
  start-page: 859
  year: 2004
  ident: 1253_CR13
  publication-title: Hypertension
  doi: 10.1161/01.HYP.0000146691.51307.84
– volume: 271
  start-page: 840
  year: 1994
  ident: 1253_CR4
  publication-title: Framingham Heart Study JAMA
– volume: 147
  start-page: 109
  year: 2015
  ident: 1253_CR26
  publication-title: Chest
  doi: 10.1378/chest.14-0321
– volume: 352
  start-page: 854
  year: 1998
  ident: 1253_CR12
  publication-title: Lancet
  doi: 10.1016/S0140-6736(98)07037-8
– volume: 114
  start-page: 119
  year: 2006
  ident: 1253_CR22
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.105.595140
– volume: 82
  start-page: 18N
  year: 1998
  ident: 1253_CR17
  publication-title: Am J Cardiol
  doi: 10.1016/S0002-9149(98)00736-X
– volume: 120
  start-page: 1640
  year: 2009
  ident: 1253_CR20
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.109.192644
– volume: 38
  start-page: 2599
  year: 2017
  ident: 1253_CR9
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehx316
– volume: 108
  start-page: 56
  year: 2011
  ident: 1253_CR8
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2011.03.004
– volume: 110
  start-page: 1042
  year: 2004
  ident: 1253_CR23
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000140263.20897.42
– volume: 28
  start-page: S37
  issue: Suppl 1
  year: 2005
  ident: 1253_CR19
  publication-title: Diab Care
  doi: 10.2337/diacare.28.suppl_1.S37
– volume: 8
  start-page: 17829
  year: 2018
  ident: 1253_CR15
  publication-title: Sci Rep
  doi: 10.1038/s41598-018-35928-w
– volume: 129
  start-page: 837
  year: 2014
  ident: 1253_CR3
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.113.005119
– volume: 105
  start-page: 315
  year: 2005
  ident: 1253_CR25
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2005.02.050
– volume: 130
  start-page: 2071
  year: 2014
  ident: 1253_CR18
  publication-title: Circulation
  doi: 10.1161/CIR.0000000000000040
– volume: 18
  start-page: 209
  year: 2008
  ident: 1253_CR16
  publication-title: J Epidemiol
  doi: 10.2188/jea.JE2008021
– volume: 49
  start-page: 565
  year: 2007
  ident: 1253_CR24
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2006.08.060
SSID ssj0017809
Score 2.2605731
Snippet To estimate the prevalence of elevated blood glucose level (EBG, including type 2 diabetes mellitus and impaired fasting glucose), and its association with...
Background To estimate the prevalence of elevated blood glucose level (EBG, including type 2 diabetes mellitus and impaired fasting glucose), and its...
Abstract Background To estimate the prevalence of elevated blood glucose level (EBG, including type 2 diabetes mellitus and impaired fasting glucose), and its...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 270
SubjectTerms Adult
Age
Age Factors
Aged
Alcohol
Analysis
Atrial fibrillation
Atrial Fibrillation - diagnosis
Atrial Fibrillation - epidemiology
Biomarkers - blood
Blood glucose
Blood Glucose - analysis
Blood pressure
Blood tests
Cardiac arrhythmia
Cardiovascular disease
China - epidemiology
Cholesterol
Chronic obstructive pulmonary disease
Cities and towns
Cross-Sectional Studies
Data collection
Diabetes
Diabetes mellitus (non-insulin dependent)
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - diagnosis
Diabetes Mellitus, Type 2 - epidemiology
EKG
Electrocardiography
Fasting
Female
Fibrillation
Glucose
Glucose Intolerance - blood
Glucose Intolerance - diagnosis
Glucose Intolerance - epidemiology
Health risk assessment
Heart
Heart attacks
Humans
Hyperglycemia
Hypertension
Hyperthyroidism
Impaired fasting glucose
Kidney diseases
Male
Males
Metabolic disorders
Middle Aged
Non-valvular atrial fibrillation
Population
Population studies
Prevalence
Prognosis
Questionnaires
Regression analysis
Risk Assessment
Risk Factors
Rural areas
Sex
Sex Factors
Substance abuse treatment
Time Factors
Type 2 diabetes
Type 2 diabetes mellitus
Up-Regulation
Womens health
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LaxUxFA7ShbgR345WiSAIQmgyeY67KpYi1JWF7kJeY4XLtNh7Xbjwt3tOJvdyB0E3LmeSGfI4yflCvvMdQl6rZIac88gSj4bBk2aut5qlLPC1VKaGj519Nqfn6tOFvthL9YWcsFkeeB64I2mViUUn1D8Eb5IDIPykhphT0FGHGkcOPm97mGr3B9bxod1hCmeObmAXtkhBQOl_LZlZeKEq1v_nlrznk5Z8yT0HdHKP3G3IkR7PLb5PbpXpAbl91u7GH5JfeyNNG_2KYvQ4oMlMK0GdNoI6XSFViIYpUzj9MzC2H8hGpaHm8KAjhgGsZpLcOxrofK9AMRKFAl6kYFbT15-XVxuK6bDXtErUPiLnJx-_fDhlLbsCS4By1kyqwF0ZxTDaLFxJOkQnpFBF8JBGHY3pOabl6FEAR8F42pDHokbJh9z3Y5KPyQG0sTwlVBWN5BO8guRKCBMBBOg-BvD98OdedYRvR9unJj2OGTBWvh5BnPHzBHmYII8T5E1H3u4-uZ51N_5W-T1O4a4iSmbXF2BIvhmS_5chdeQNGoDHhQ2NS6HFJ0AXUSLLHxtEXwrOYx05XNSEBZmWxVsT8m1DuPEAXB0gK22h-NWuGL9EkttUrja1DpcWELvsyJPZ4nZdAphnB-1cR-zCFhd9XpZM3y6rXLhxTho3PPsfg_Sc3OnrKhKsd4fkYP19U14AKlvHl3UB_gayVjSj
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LixQxEA66gngR37auEkEQhLCdd9qLrOKyCOvJhbmFdNK9Kwzd686MBw_-dqvSmXEaYY_TSQ95VJIvXV99RchbFU2TUupZrFvD4JdmTljNYuL4WCqTw8fOvpnTc_V1oRflg9uq0Cq3e2LeqNMY8Rv5EZz8Do4mbcXHq58Ms0ahd7Wk0LhN7qB0GVq1XewuXNy6uimeTO7M0Qr2YotEBEwAoCUzs7MoS_b_vzHvnUxz1uTeMXTygNwv-JEeTxP-kNzqhkfk7lnxkD8mf_bGmxYSFsUYcsCUiWaaOi00dbpEwhANQ6LDODAwuV_ISaUhZ_KgPQYDLCeq3Aca6ORdoBiPQgE1UjCu4eL35bihmBR7TbNQ7RNyfvLl--dTVnIssAhYZ82kCrXret70NnHXRR1axyVXHa9D7HVrjKgxOYdAGRwF42lD6jvVy7pJQvRRPiUH0MbuOaGq00hBQUdkrTg3LUABLdoACAD-WaiK1NvR9rEIkGMejKXPFxFn_DRBHibI4wR5U5H3u1euJvWNmyp_wincVUTh7PxgvL7wZR16aZVpOx1RThPASQpwYYyqaVMMutXBVuQdGoDH5Q2Ni6FEKUAXUSjLHxvEYApuZRU5nNWEZRnnxVsT8mVbWPl_RlyRN7tifBOpbkM3bnKdWlrA7bIizyaL23UJwJ5ttHMVsTNbnPV5XjL8uMyi4cY5aVzz4uZmvST3RF4fnAl3SA7W15vuFaCudfs6L62_ZTQsEQ
  priority: 102
  providerName: ProQuest
Title Association between elevated blood glucose level and non-valvular atrial fibrillation: a report from the Guangzhou heart study
URI https://www.ncbi.nlm.nih.gov/pubmed/31779588
https://www.proquest.com/docview/2328293572
https://www.proquest.com/docview/2320379993
https://pubmed.ncbi.nlm.nih.gov/PMC6883689
https://doaj.org/article/3746be5c8080426da871c49bdca5b5a7
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3ra9RAEB_6APGL-G60HisIghDNY18RSulJSxGuSPHg8Muy2U1a4cjp9U60H_q3O7PJnRcsgl8OLrsJ2Z2Z3d9mfjMD8Io7WXjv69glpYzxn4h1pkTsfEqXcy5D-NjoTJ6O-ceJmGzBqrxVN4FXtx7tqJ7UeD59-_P7r0M0-INg8Fq-u8I1VhHBgBL7izyW27CLG5OiggYj_sepoHRgfKS4HseIOtLOyXnrI3rbVMjm__eavbFp9QmVGzvUyX2410FLdtTqwgPYqpqHcGfUOc8fwc2GKFjHz2IUXo5w07PAYGcdg51NiUvEbONZM2ti1MYfRFdlNhT5YDXFCUxbFt17ZlnreGAUqsIQUDLUu-bi-nK2ZFQve8FCDtvHMD45_vzhNO7KL8QOYdAizrlNdFWnRa18qisnbKnTPOVVmlhXi1LKLKG6HRllyOE4t8r6uuJ1nhQ-y2qXP4EdfMdqDxivBLFTyEeZ8DSVJaIEkZUWwQE-OeMRJKvZNq7LTU4lMqYmnFG0NK2ADArIkICMjODN-pZvbWKOf3UekgjXHSmndrgwm1-YzkRNrrgsK-Eo0ybiFm_xLOl4UXpnRSmsiuA1KYAhXcSXc7YLYMAhUg4tcyQJnnE8sEWw3-uJFuv6zSsVMiuFN4hsNUIvobD55bqZ7iQWXFPNlqFPkiuE9HkET1uNWw8JcaAqhNYRqJ4u9sbcb2m-XoZ84lLrXOri2f_M6HO4mwVrQVPS-7CzmC-rFwjPFuUAttVEDWB3eHz26XwQPnIMgiHi7_nwy2-VYzj8
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKkYAL4k2ggJFASEhRE8evICFUHtWWdntqpb0Zx3ZapFVSursgOPCT-I3MONllI6Teekw8iezMeB7xNzOEvOBOlt77OnVZJVO4EqlmSqTO53i74DKmj40P5eiYf56IyQb5s8yFQVjlUidGRe1bh__It8HyazBNQrF3Z99S7BqFp6vLFhqdWOyHnz8gZJu93fsI_H3J2O6now-jtO8qkDqw7vO04DbToc7LWvlcBydspfMi5yHPrKtFJSXLsB0Fw8IvXGelsr4OvC6y0jNWuwLee4VcBcObYbCnJqsAL1dA3Z-c5lpuz0D3KwQ-YMMBUaRyYPtii4D_DcGaJRyiNNfM3u4tcrP3V-lOJ2C3yUZo7pBr4_5E_i75vcZf2oO-KOasgw_raYTF0x4WT6cIUKK28bRpmxRE_DtiYKmNnUNojckH0w6a94Za2p1mUMx_oeClUhDm5uTXabug2IR7TmNh3Hvk-FK-_n2yCXMMDwnlQSDkBQ8-M57nsgLXQ7DKgscBb2Y8IdnyaxvXFzzHvhtTEwMfLU3HIAMMMsggIxPyevXIWVft4yLi98jCFSEW6o432vMT0-97UyguqyAclu8EZ8hbCFAdLyvvrKiEVQl5hQJgUJ3A5JztsyJgiViYy-xI9Pk4RIEJ2RpQghpww-GlCJleDc3Mv02TkOerYXwSoXVNaBeRJisUxAlFQh50ErdaEjiXqhRaJ0QNZHGw5uFI8_U0FimXWhdSl48untYzcn10ND4wB3uH-4_JDRb3Sp4yvUU25-eL8AQ8vnn1NG4zSr5c9r7-C7J0Z9o
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+between+elevated+blood+glucose+level+and+non-valvular+atrial+fibrillation%3A+a+report+from+the+Guangzhou+heart+study&rft.jtitle=BMC+cardiovascular+disorders&rft.au=Fu%2C+Lu&rft.au=Deng%2C+Hai&rft.au=Lin%2C+Wei-dong&rft.au=He%2C+Shang-fei&rft.date=2019-11-28&rft.issn=1471-2261&rft.eissn=1471-2261&rft.volume=19&rft.issue=1&rft_id=info:doi/10.1186%2Fs12872-019-1253-6&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s12872_019_1253_6
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2261&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2261&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2261&client=summon